These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14944544)

  • 1. Dextran sulphate--a synthetic analogue of heparin.
    RICKETTS CR
    Biochem J; 1952 Apr; 51(1):129-33. PubMed ID: 14944544
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic trial of the synthetic heparin analogue dextran sulphate.
    RICKETTS CR; WALTON KW; VAN LEUVEN BD; BIRBECK A; BROWN A; KENNEDY AC; BURT CC
    Lancet; 1953 Nov; 265(6794):1004-10. PubMed ID: 13110037
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of the in vitro and in vivo effects of a synthetic heparin-like anticoagulant: dextran sulphate.
    HJORT P; STORMORKEN H; GILJE O
    Scand J Clin Lab Invest; 1957; 9 Suppl 29():1-86. PubMed ID: 13506569
    [No Abstract]   [Full Text] [Related]  

  • 4. The anticoagulant activity of dextran sulphate. I. An in vitro comparison between the actions of dextran sulphate and heparin on the various stages of blood coagulation.
    FORWELL GD; INGRAM GI
    J Pharm Pharmacol; 1956 Jul; 8(7):530-45. PubMed ID: 13346452
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo and in vitro comparative assays of the anticoagulant activity of dextran sulphate and heparin.
    GRASSET E; SCHWARTZ DE
    Br J Pharmacol Chemother; 1955 Sep; 10(3):317-20. PubMed ID: 13269707
    [No Abstract]   [Full Text] [Related]  

  • 6. Heparinoid and heparin; an investigation into the anticoagulant effect of the dextran sulphate dexulate.
    ARGE E
    Acta Med Scand; 1956 Nov; 155(6):469-74. PubMed ID: 13372201
    [No Abstract]   [Full Text] [Related]  

  • 7. Vascular effects of heparin, dextran sulphate, and 5-hydroxytryptamine.
    LAMBERT HP
    Clin Sci; 1958 Nov; 17(4):621-8. PubMed ID: 13608972
    [No Abstract]   [Full Text] [Related]  

  • 8. [The toxicity of dextran sulfate, a synthetic anticoagulant of the heparin type].
    SASAKI S; TAKEMOTO T; OKA S
    C R Seances Soc Biol Fil; 1957; 151(10):1799-803. PubMed ID: 13547622
    [No Abstract]   [Full Text] [Related]  

  • 9. The mechanism of the prolonged bleeding time provoked by dextran sulphate or by excessive doses of heparin.
    BORCHGREVINK CF
    Acta Med Scand; 1961 Sep; 170():365-73. PubMed ID: 13871206
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biological and clinical study of a synthetic heparinic substance: dextran sulfate].
    DONZELOT E; KAUFMANN H; DAUZIER G
    Sem Hop; 1955 Apr; 31(26):1475-80. PubMed ID: 14385872
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inactivating property of various substances against the anticoagulant effect of heparin & dextran sulfate].
    AGOLINI G
    Boll Soc Ital Biol Sper; 1957 Jun; 33(6):874-6. PubMed ID: 13499727
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic toxicity of dextran sulphate in rabbits.
    HINT HC; RICHTER AW
    Br J Pharmacol Chemother; 1958 Jun; 13(2):109-12. PubMed ID: 13536272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heparinoid and heparin; anticoagulant effects of dexulate, a dextran sulfate preparation].
    ARGE E
    Ugeskr Laeger; 1957 Feb; 119(9):248-51. PubMed ID: 13422709
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of heparin and dextran sulphate on the production of collagen and protein in diabetic and non-diabetic human skin fibroblast cultures.
    Kjellström T; Malmquist J
    Med Biol; 1983 Jun; 61(3):186-90. PubMed ID: 6195494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro.
    Baba M; Pauwels R; Balzarini J; Arnout J; Desmyter J; De Clercq E
    Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6132-6. PubMed ID: 2457906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effects of heparin and dextran sulfate alone and combined with ACTH and cortisone, on the coagulant action of viper venoms].
    GRASSET E; SCHWARTZ DE
    Bull Schweiz Akad Med Wiss; 1955 May; 11(1-2):10-22. PubMed ID: 14389908
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of mucopolysaccharides on penicillin-induced lysis of Staphylococcus aureus.
    Kiriyama T; Miyake Y; Sugai M; Kobayashi K; Yoshiga K; Takada K; Suginaka H
    J Med Microbiol; 1987 Dec; 24(4):325-31. PubMed ID: 2447280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biological behaviour of a new synthetic anticoagulant (dextran sulphate) possessing heparin-like properties.
    WALTON KW
    Br J Pharmacol Chemother; 1952 Sep; 7(3):370-91. PubMed ID: 12978241
    [No Abstract]   [Full Text] [Related]  

  • 19. EFFECTS OF THE LONG-TERM ADMINSTRATION TO ANIMALS OF DEXTRAN SULPHATE.
    ELLIS HA
    J Pathol Bacteriol; 1965 Apr; 89():437-60. PubMed ID: 14320286
    [No Abstract]   [Full Text] [Related]  

  • 20. IN VIVO AND IN VITRO EFFECTS OF DEXTRAN SULPHATES, HEPARIN AND PELENTAN ON GUINEA-PIG COMPLEMENT, "ANTIBODY COFACTOR" AND NONSPECIFIC VIRAL INHIBITORS.
    STYK B; KOCISKOVA D
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():485-96. PubMed ID: 14238947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.